For us, halfway through the 2020s, it’s Mounjaro vs Ozempic, the battle of the fat jabs. In the first ever head-to-head ...

IT ONCE boasted over five million subscribers and saw one million of us stepping onto the scales every year. But ...

Chrissy Metz is turning heads and spreading springtime joy as she celebrates her incredible weight loss transformation! The ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

NPR international correspondent Emily Feng and Axios chief financial correspondent Felix Salmon speak with Bianna Golodryga about the ‘insane amount of uncertainty’ around US trade policy ...

As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.